Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study

Author:

Ruwald A C12,Gislason G H2345,Vinther M2,Johansen J B6,Nielsen J C7,Philbert B T8,Torp-Pedersen C9,Riahi S10,Jøns C8

Affiliation:

1. Department of Medicine, Sjaellands University Hospital, Sygehusvej 10, Roskilde, Denmark

2. Department of Cardiology, Herlev-Gentofte University Hospitals, Kildegaardsvej 28, Hellerup, Denmark

3. National Institute of Public Health, Øster Farimagsgade 5 A, Copenhagen, Denmark

4. Department of Cardiology, University of Southern Denmark, Sdr. Boulevard 29, Odense, Denmark

5. The Danish Heart Foundation, Vognmagergade 7, 3. sal, Copenhagen, Denmark

6. Department of Cardiology, Odense University Hospital, Kløvervænget 47, Odense, Denmark

7. Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, Denmark

8. Department of Cardiology, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark

9. Institute of Health, Science and Technology, Aalborg University, Niels Jernes Vej 10, Aalborg and Aalborg University Hospital, Hobrovej 18-22, 9100 Aalborg, Denmark

10. Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, Aalborg, Denmark

Funder

The Danish Council for Independent Research

Biotronik

Bristol-Myers-Squib

Novo Nordisk Foundation

Bristol-Myers Squibb

Pfizer

Bayer

AstraZeneca

Boehringer Ingelheim

Biotronik and Biosense Webster

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference24 articles.

1. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC);Priori;Europace,2015

2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Ponikowski;Eur J Heart Fail,2016

3. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF);Lancet,1999

4. Effect of carvedilol on survival in severe chronic heart failure;Packer;N Engl J Med,2001

5. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the MERIT-HF Study Group;Hjalmarson;JAMA,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3